<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="deo2411" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">DEN Open</journal-id><journal-id journal-id-type="iso-abbrev">DEN Open</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2692-4609</journal-id><journal-id journal-id-type="publisher-id">DEO2</journal-id><journal-title-group><journal-title>DEN Open</journal-title></journal-title-group><issn pub-type="epub">2692-4609</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39050142</article-id><article-id pub-id-type="pmc">PMC11266432</article-id>
<article-id pub-id-type="doi">10.1002/deo2.411</article-id><article-id pub-id-type="publisher-id">DEO2411</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Establishment of a swine model of delayed bleeding after endoscopic procedure</article-title><alt-title alt-title-type="left-running-head">UEHARA <sc>et al</sc>.</alt-title></title-group><contrib-group><contrib id="deo2411-cr-0001" contrib-type="author"><name><surname>Uehara</surname><given-names>Shohei</given-names></name><xref rid="deo2411-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2411-cr-0002" contrib-type="author" corresp="yes"><name><surname>Sasaki</surname><given-names>Fumisato</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4824-4154</contrib-id><xref rid="deo2411-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>bungohs@m2.kufm.kagoshima-u.ac.jp</email></address></contrib><contrib id="deo2411-cr-0003" contrib-type="author"><name><surname>Sahara</surname><given-names>Hisashi</given-names></name><xref rid="deo2411-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo2411-cr-0004" contrib-type="author"><name><surname>Tanaka</surname><given-names>Akihito</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9111-0955</contrib-id><xref rid="deo2411-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2411-cr-0005" contrib-type="author"><name><surname>Hinokuchi</surname><given-names>Makoto</given-names></name><xref rid="deo2411-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2411-cr-0006" contrib-type="author"><name><surname>Maeda</surname><given-names>Hidehito</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8244-3977</contrib-id><xref rid="deo2411-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2411-cr-0007" contrib-type="author"><name><surname>Arima</surname><given-names>Shiho</given-names></name><xref rid="deo2411-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2411-cr-0008" contrib-type="author"><name><surname>Hashimoto</surname><given-names>Shinichi</given-names></name><xref rid="deo2411-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2411-cr-0009" contrib-type="author"><name><surname>Kanmura</surname><given-names>Shuji</given-names></name><xref rid="deo2411-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2411-cr-0010" contrib-type="author"><name><surname>Ido</surname><given-names>Akio</given-names></name><xref rid="deo2411-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="deo2411-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Digestive and Lifestyle Diseases</named-content>
<institution>Kagoshima University Graduate School of Medical and Dental Sciences</institution>
<city>Kagoshima</city>
<country country="JP">Japan</country>
</aff><aff id="deo2411-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Division of Experimental Large Animal Research</named-content>
<named-content content-type="organisation-division">Life Science and Laboratory Animal Research Unit</named-content>
<named-content content-type="organisation-division">Center for Advanced Science Research and Promotion</named-content>
<institution>Kagoshima University</institution>
<city>Kagoshima</city>
<country country="JP">Japan</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>Fumisato Sasaki, Digestive and Lifestyle Diseases, Kagoshima University Graduate School of Medical and Dental Sciences, 8&#x02010;35&#x02010;1, Sakuragaoka, Kagoshima 890&#x02013;8520, Japan.<break/> Email: <email>bungohs@m2.kufm.kagoshima-u.ac.jp</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>7</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><volume>5</volume><issue seq="103">1</issue><issue-id pub-id-type="doi">10.1002/deo2.v5.1</issue-id><elocation-id>e411</elocation-id><history>
<date date-type="rev-recd"><day>01</day><month>7</month><year>2024</year></date>
<date date-type="received"><day>01</day><month>5</month><year>2024</year></date>
<date date-type="accepted"><day>06</day><month>7</month><year>2024</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2024 The Author(s). <italic toggle="yes">DEN Open</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:DEO2-5-e411.pdf"/><abstract><title>Abstract</title><sec id="deo2411-sec-0010"><title>Objectives</title><p>Although delayed bleeding after endoscopic procedures has become a problem, currently, there are no appropriate animal models to validate methods for preventing it. This study aimed to establish an animal model of delayed bleeding after endoscopic procedures of the gastrointestinal tract.</p></sec><sec id="deo2411-sec-0020"><title>Methods</title><p>Activated coagulation time (ACT) was measured using blood samples drawn from a catheter inserted into the external jugular vein of swine (<italic toggle="yes">n</italic> = 7; age, 6 months; mean weight, 13.8 kg) under general anesthesia using the cut&#x02010;down method. An upper gastrointestinal endoscope was inserted orally, and 12 mucosal defects were created in the stomach by endoscopic mucosal resection using a ligating device. Hemostasis was confirmed at this time point. The heparin group (<italic toggle="yes">n</italic> = 4) received 50 units/kg of unfractionated heparin via a catheter; after confirming that the ACT was &#x02265;200 s 10 min later, continuous heparin administration (50 units/kg/h) was started. After 24 h, an endoscope was inserted under general anesthesia to evaluate the blood volume in the stomach and the degree of blood adherence at the site of the mucosal defect.</p></sec><sec id="deo2411-sec-0030"><title>Results</title><p>Delayed bleeding was observed in three swine (75%) in the heparin&#x02010;treated group, who had a maximum ACT of &#x0003e;220 s before the start of continuous heparin administration. In the non&#x02010;treated group (<italic toggle="yes">n</italic> = 3), no prolonged ACT or delayed bleeding was observed at 24 h.</p></sec><sec id="deo2411-sec-0040"><title>Conclusion</title><p>An animal model of delayed bleeding after an endoscopic procedure in the gastrointestinal tract was established using a single dose of heparin and continuous heparin administration after confirming an ACT of 220 s.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="deo2411-kwd-0001">animal model</kwd><kwd id="deo2411-kwd-0002">delayed bleeding</kwd><kwd id="deo2411-kwd-0003">endoscopic resection</kwd><kwd id="deo2411-kwd-0004">heparin</kwd><kwd id="deo2411-kwd-0005">miniature swine</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI.</funding-source><award-id>No.23K15016</award-id></award-group></funding-group><counts><fig-count count="5"/><table-count count="1"/><page-count count="7"/><word-count count="3929"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:27.02.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="deo2411-sec-0050"><title>INTRODUCTION</title><p>Endoscopic submucosal dissection (ESD) and resection (EMR) are well&#x02010;established treatments for early gastric tumors.<xref rid="deo2411-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> Delayed bleeding occurs in 1.8&#x02013;15.6% of patients after ESD.<xref rid="deo2411-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="deo2411-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="deo2411-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="deo2411-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="deo2411-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> Several studies have shown that antithrombotic agents and resection size are significant risk factors for bleeding after ESD.<xref rid="deo2411-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="deo2411-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="deo2411-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> According to a predictive model based on risk stratification for causing post&#x02010;ESD ulcer bleeding (BEST&#x02010;J score) recently reported by Hatta et&#x000a0;al., the rate of delayed bleeding is 2.8% in the low&#x02010;risk group, whereas it is 29.7% in the very&#x02010;high&#x02010;risk group.<xref rid="deo2411-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> With the advent of an aging society, the number of patients receiving antithrombotic drugs is increasing,<xref rid="deo2411-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="deo2411-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> and delayed bleeding after ESD has become a great problem. Bleeding after an endoscopic procedure can sometimes be controlled by endoscopic hemostasis by coagulation of the blood vessels with electrocautery, hemostatic forceps, or by suturing with endoclips.<xref rid="deo2411-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> However, it can sometimes lead to life&#x02010;threatening conditions requiring blood transfusion, arterial embolization with vascular interventional radiology, or emergency surgery.<xref rid="deo2411-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="deo2411-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="deo2411-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> The most appropriate method for preventing delayed bleeding after ESD remains unknown.<xref rid="deo2411-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> Although animal models simulating gastrointestinal bleeding have been reported, they have not been widely used because of the time and cost involved and the need for a surgical approach.<xref rid="deo2411-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="deo2411-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="deo2411-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> Recently, animal models of intraoperative bleeding with anticoagulants<xref rid="deo2411-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> and bolus administration of heparin<xref rid="deo2411-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> for endoscopic hemostasis training have been reported. However, to the best of our knowledge, there are no appropriate animal models to validate prophylaxis for delayed bleeding. This study aimed to establish an animal model of delayed bleeding after endoscopic procedures of the gastric mucosa.</p></sec><sec id="deo2411-sec-0060"><title>MATERIALS AND METHODS</title><sec id="deo2411-sec-0070"><title>Experimental animals</title><p>Seven CLAWN miniature swine (age, 6 months; weight, 13&#x02013;14 kg; procured from the Kagoshima Miniature Swine Research Center) were used in the present study. Miniature swine were injected intramuscularly with 15 mg/kg ketamine (Daiichi Sankyo Propharma Co., Ltd.) and 2 mg/kg xylazine (Bayer Yakuhin, Ltd.) as premedications. An endotracheal tube (Smith Medical Japan) was inserted, and anesthesia was maintained using isoflurane (DS Pharma Animal Health Co., Ltd.).<xref rid="deo2411-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>
</p><p>An upper gastrointestinal endoscope was inserted orally into seven swine to create a mucosal defect site in the stomach using an EMR with ligation (EMR&#x02010;L) technique.<xref rid="deo2411-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="deo2411-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> Four swine were treated with heparin, whereas three were not. Heparin was administered via a catheter inserted into the external jugular vein.</p><p>The animals were excluded from solid food consumption from the day before the experiment until the day after the experiment, with free access to water. Feeding was performed by a specialized animal experimenter at the Kagoshima University Animal Experimental Facility, and symptoms were checked daily by the experimenter. Necropsies were performed by several experimenters in accordance with the ethical guidelines of the Kagoshima University Animal Experimentation Facility. No proton pump inhibitor was administered after EMR&#x02010;L. Animal care, housing, and surgery were performed in accordance with the guidelines of the Kagoshima University Animal Experiment Committee.</p></sec><sec id="deo2411-sec-0080"><title>Catheter insertion</title><p>Catheters (Argyle Fukuroi, CV catheter, 14 G &#x000d7; 30 cm; Cardinal Health) were inserted for blood sampling and heparin administration. Under general anesthesia, the catheters were inserted into the bilateral external jugular veins using the cut&#x02010;down method.<xref rid="deo2411-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> One catheter was inserted for blood collection and the other for heparin administration.</p></sec><sec id="deo2411-sec-0090"><title>EMR&#x02010;L procedure</title><p>Twelve artificial gastric ulcers were created by an endoscopist who performed EMR&#x02010;L using an upper gastrointestinal endoscope (GIF&#x02010;Q260J; Olympus) and a video scope system (EVIS LUCERA CV&#x02010;260SL; Olympus) to obtain reliable data on delayed bleeding. Markings were made on the lesser curvature, anterior wall, and posterior wall of the upper gastric body and middle gastric body, gastric angle, and lower gastric body respectively; using the tip of the polypectomy snare (Captivator II 15 mm; Boston Scientific) in coagulation mode, for a total of 12 locations (Figure&#x000a0;<xref rid="deo2411-fig-0001" ref-type="fig">1</xref>). One milliliter of 0.9% saline (Otsuka Pharmaceutical Co. Ltd.) mixed with indigo carmine was injected locally using an injection needle with adequate lifting of the submucosa. Endoscopic variceal ligation (EVL) was performed using a ligating device (Pneumo Activate EVL device; Sumitomo Bakelite), followed by snaring with a polypectomy snare and pulse&#x02010;cut resection with a high&#x02010;frequency device (Pulse&#x02010;Cut Fast mode, 120 W, ESG&#x02010;100; Olympus).<xref rid="deo2411-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="deo2411-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> All EMR&#x02010;Ls were performed by Shohei Uehara.</p><fig position="float" fig-type="FIGURE" id="deo2411-fig-0001"><label>FIGURE 1</label><caption><p>
<bold>Endoscopic findings of ulcers after endoscopic submucosal resection with ligation</bold>. Ulcers are created using endoscopic submucosal resection with ligation at 12 locations: lesser curvature, anterior wall, and posterior wall of the upper gastric body and middle gastric body, gastric angle, and lower gastric body respectively.</p></caption><graphic xlink:href="DEO2-5-e411-g004" position="anchor" id="jats-graphic-1"/></fig></sec><sec id="deo2411-sec-0100"><title>Heparin administration, activated coagulation time measurement, and swine dissection</title><p>The experimental protocol is illustrated in Figure&#x000a0;<xref rid="deo2411-fig-0002" ref-type="fig">2</xref>. A variety of antithrombotic drugs are used in clinical practice, including antiplatelet agents such as aspirin and anticoagulants such as warfarin and direct&#x02010;acting oral anticoagulants. Heparin was chosen for this study because it is easy to administer intravenously and can be adjusted using activated coagulation time (ACT) as an indicator. After EMR&#x02010;L, 50 units/kg of unfractionated heparin (heparin sodium; Mochida Pharmaceutical Co., Ltd.) was administered intravenously; after 10 min, ACT was measured using a coagulation analyzer (Hemochron Jr Signature+; Accriva Diagnostics, Inc.). Administration of 50 U/kg unfractionated heparin was repeated every 10 min until the ACT was &#x0003e;200 s. The protocol was based on previous reports.<xref rid="deo2411-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> Continuous heparin administration (50 U/kg/h) was initiated after the ACT was &#x0003e;200 s, using a portable disposable infusion pump (SUREFUSER A, SFS&#x02010;1002D, Sustained flow 2.1 mL/h; NIPRO). We measured ACT at 0.5, 1, 2, and 4 h after starting continuous heparin administration. After 24 h, the swine was examined endoscopically to assess the blood volume in the stomach and the extent of blood adherence to mucosal defects. The animal was sacrificed at the end of the procedure by intravenous injection of thiamylal sodium (ISOZOL; Nichi&#x02010;Iko Pharmaceutical Co., Ltd.) 90 mg/kg and potassium chloride (Terumo Corporation) 20 mEq.<xref rid="deo2411-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> The abdomen of the dead swine was dissected and the stomach was removed.</p><fig position="float" fig-type="FIGURE" id="deo2411-fig-0002"><label>FIGURE 2</label><caption><p>
<bold>Experimental protocol</bold>. The protocols followed in the heparin&#x02010;treated and non&#x02010;treated groups are shown.</p></caption><graphic xlink:href="DEO2-5-e411-g003" position="anchor" id="jats-graphic-3"/></fig></sec><sec id="deo2411-sec-0110"><title>Outcome measures</title><p>The primary endpoint was the presence or absence of clots in the stomach. The secondary endpoint was the number of ulcer bottoms with attached clots. The scope was inserted again 24 h after the procedure under general anesthesia, the presence of intragastric clots was confirmed by endoscopic observation, and the number of clots at the base of the ulcer was counted. The presence or absence of hematemesis on the day after the procedure was also checked, as well as the presence or absence of tar stools at autopsy. Hemoglobin levels were measured immediately after catheter insertion and between anesthesia and endoscopic observation on the day after the procedure and compared. A swine was considered to have delayed bleeding if at least one of the following conditions was met: obvious overt gastrointestinal bleeding such as hematemesis or hematemesis 24 h after the procedure and endoscopy showing a clot or blood retention in the stomach.</p></sec><sec id="deo2411-sec-0120"><title>Statistical analyses</title><p>The statistical significance of the difference between the two groups was calculated using the Student's t&#x02010;test or Welch's t&#x02010;test, depending on the results of the Levine test for normality and equality of variances. Statistical significance was set at <italic toggle="yes">p</italic> &#x0003c; 0.05. All statistical analyses were performed using IBM SPSS Statistics Base 29 software (IBM Corp.).<xref rid="deo2411-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>
</p></sec></sec><sec id="deo2411-sec-0130"><title>RESULTS</title><p>The characteristics and results for each swine are shown in Table&#x000a0;<xref rid="deo2411-tbl-0001" ref-type="table">1</xref>. There was no significant difference in mean body weights between the heparin&#x02010;treated and non&#x02010;treated (13.9 kg vs. 13.5 kg, respectively) models. The diameter of all the ulcer beds (<italic toggle="yes">n</italic> = 12) was approximately 10 mm. The submucosal layer remained at the base of the ulcer, and the muscular layer was visible. No obvious perforations or persistent bleeding was observed.</p><table-wrap position="float" id="deo2411-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Characteristics and outcomes of the two distinct models.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Model No.</th><th align="left" rowspan="1" colspan="1">Body weight (kg)</th><th align="left" rowspan="1" colspan="1">Heparin administration</th><th align="left" rowspan="1" colspan="1">Continuous heparin dose</th><th align="left" rowspan="1" colspan="1">ACT at the start of continuous heparin</th><th align="left" rowspan="1" colspan="1">Max ACT</th><th align="left" rowspan="1" colspan="1">Vomiting blood</th><th align="left" rowspan="1" colspan="1">Intragastric hematoma</th><th align="left" rowspan="1" colspan="1">Intragastric blood</th><th align="left" rowspan="1" colspan="1">Blood clots in ulcers</th><th align="left" rowspan="1" colspan="1">Number of blood clots adhered</th><th align="left" rowspan="1" colspan="1">Hb before EMR&#x02010;L</th><th align="left" rowspan="1" colspan="1">Hb after EMR&#x02010;L</th><th align="left" rowspan="1" colspan="1">Tarry stool</th><th align="left" rowspan="1" colspan="1">Delayed bleeding</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">13.1</td><td align="left" rowspan="1" colspan="1">+</td><td align="left" rowspan="1" colspan="1">50 U/kg/h</td><td align="left" rowspan="1" colspan="1">227</td><td align="left" rowspan="1" colspan="1">227</td><td align="left" rowspan="1" colspan="1">+</td><td align="left" rowspan="1" colspan="1">+</td><td align="left" rowspan="1" colspan="1">+</td><td align="left" rowspan="1" colspan="1">+</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">10.6</td><td align="left" rowspan="1" colspan="1">11.6</td><td align="left" rowspan="1" colspan="1">Cecum</td><td align="left" rowspan="1" colspan="1">+</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">14.7</td><td align="left" rowspan="1" colspan="1">+</td><td align="left" rowspan="1" colspan="1">50 U/kg/h</td><td align="left" rowspan="1" colspan="1">252</td><td align="left" rowspan="1" colspan="1">252</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">+</td><td align="left" rowspan="1" colspan="1">+</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">11.7</td><td align="left" rowspan="1" colspan="1">8.8</td><td align="left" rowspan="1" colspan="1">Ileum</td><td align="left" rowspan="1" colspan="1">+</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">13.9</td><td align="left" rowspan="1" colspan="1">+</td><td align="left" rowspan="1" colspan="1">50 U/kg/h</td><td align="left" rowspan="1" colspan="1">201</td><td align="left" rowspan="1" colspan="1">201</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">+</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">11.4</td><td align="left" rowspan="1" colspan="1">14.4</td><td align="left" rowspan="1" colspan="1">None</td><td align="left" rowspan="1" colspan="1">&#x02010;</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">14.0</td><td align="left" rowspan="1" colspan="1">+</td><td align="left" rowspan="1" colspan="1">50 U/kg/h</td><td align="left" rowspan="1" colspan="1">273</td><td align="left" rowspan="1" colspan="1">273</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">+</td><td align="left" rowspan="1" colspan="1">+</td><td align="left" rowspan="1" colspan="1">+</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">11.3</td><td align="left" rowspan="1" colspan="1">9.9</td><td align="left" rowspan="1" colspan="1">Cecum</td><td align="left" rowspan="1" colspan="1">+</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">12.4</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">103</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">13.8</td><td align="left" rowspan="1" colspan="1">None</td><td align="left" rowspan="1" colspan="1">&#x02010;</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">14.1</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">110</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">+</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">10.6</td><td align="left" rowspan="1" colspan="1">11.6</td><td align="left" rowspan="1" colspan="1">None</td><td align="left" rowspan="1" colspan="1">&#x02010;</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">14.1</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">119</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">&#x02010;</td><td align="left" rowspan="1" colspan="1">+</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">10.9</td><td align="left" rowspan="1" colspan="1">11.5</td><td align="left" rowspan="1" colspan="1">None</td><td align="left" rowspan="1" colspan="1">&#x02010;</td></tr></tbody></table><table-wrap-foot><fn id="deo2411-tbl1-note-0001"><p>Abbreviations: ACT, activated clotting time; EMR&#x02010;L, endoscopic submucosal resection with ligation; Hb, hemoglobin.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>Figure&#x000a0;<xref rid="deo2411-fig-0003" ref-type="fig">3</xref> summarizes the changes in ACT during heparin administration. The first three swine in the heparin&#x02010;treated group were repeatedly infused with 50 U/kg heparin until the ACT was &#x0003e;200 s. The maximum ACT before continuous heparin infusion was 227, 252, and 201 s for the first, second, and third swine, respectively. Delayed bleeding was observed in the first and second swine but not in the third. As the ACT before continuous heparin infusion was &#x0003e;220 s in the first and second swine, an additional experiment was conducted with the maximum ACT before continuous heparin infusion set to &#x0003e;220 s to increase the incidence of delayed bleeding. The maximum ACT before the continuous heparin infusion in the fourth swine was 273 s.</p><fig position="float" fig-type="FIGURE" id="deo2411-fig-0003"><label>FIGURE 3</label><caption><p>
<bold>Activated clotting time (ACT) over time in swine treated with intravenous heparin</bold>. Heparin is administered to the first three swine until the ACT is &#x0003e;200 s. The maximum ACT before continuous heparin infusion is 227 s for the first swine, 252 s for the second, and 201 s for the third.</p></caption><graphic xlink:href="DEO2-5-e411-g002" position="anchor" id="jats-graphic-5"/></fig><p>The primary endpoint was the presence or absence of blood clots in the stomach. Three of the four swine (75%) in the heparin&#x02010;treated group had large intragastric blood clots; all three had maximum ACT &#x0003e;220 s before the start of continuous heparin administration. In the non&#x02010;treated group (<italic toggle="yes">n</italic> = 3), there was no prolonged ACT or intragastric blood clot formation after 24 h (Figure&#x000a0;<xref rid="deo2411-fig-0004" ref-type="fig">4</xref>). Macroscopic observation of the resected stomach showed clots at the bottom of 10 of the 12 ulcers in the heparin&#x02010;treated group and no clots at the bottom of the ulcers in the non&#x02010;treated group (Figure&#x000a0;<xref rid="deo2411-fig-0005" ref-type="fig">5</xref>). The secondary endpoint was the number of ulcer bottoms with attached clots. The mean number of clots adherent to the bottom of the ulcer in swine with a maximum ACT of &#x02265;220 s before the start of continuous heparin administration (<italic toggle="yes">n</italic> = 3) and in the heparin non&#x02010;treated group (<italic toggle="yes">n</italic> = 3) was not significantly different (4.7 and 0.7, respectively; <italic toggle="yes">p</italic> = 0.279), but there was a trend for more clots in the heparin&#x02010;treated group.</p><fig position="float" fig-type="FIGURE" id="deo2411-fig-0004"><label>FIGURE 4</label><caption><p>
<bold>Endoscopic findings 24 h after endoscopic submucosal resection with ligation (EMR&#x02010;L)</bold>. Endoscopic findings after 24 h of EMR&#x02010;L are shown. (a&#x02013;d) show the findings in swine that had received heparin after EMR&#x02010;L. In (a), (b), and (d), the maximum activated clotting time (ACT) before the start of continuous heparin administration is &#x0003e;220 s, and a large hematoma is observed in the stomach. As shown in (c), the maximum ACT before the start of continuous heparin administration is 201 s, and no delayed bleeding is observed. (e&#x02013;g) do not show delayed bleeding as these swine did not receive heparin. EMR&#x02010;L, endoscopic submucosal resection with ligation.</p></caption><graphic xlink:href="DEO2-5-e411-g005" position="anchor" id="jats-graphic-7"/></fig><fig position="float" fig-type="FIGURE" id="deo2411-fig-0005"><label>FIGURE 5</label><caption><p>
<bold>Macro images of resected stomachs</bold>. (a) Heparin&#x02010;treated group: 10 of the 12 ulcers show clots at the bottom. (b) Non&#x02010;treated group: no clots at the bottom of the ulcer.</p></caption><graphic xlink:href="DEO2-5-e411-g001" position="anchor" id="jats-graphic-9"/></fig><p>The site of bleeding was the anterior wall of the upper gastric body (<italic toggle="yes">n</italic> = 4), the middle gastric body (<italic toggle="yes">n</italic> = 2), the anterior wall of the middle gastric body (<italic toggle="yes">n</italic> = 2), and the middle and lower gastric body (<italic toggle="yes">n</italic> = 2) of the four animals in the heparin&#x02010;treated group, and the anterior wall of the lower gastric body (<italic toggle="yes">n</italic> = 2) of the three animals in the heparin&#x02010;non&#x02010;treated group.</p><p>The ulcer bases were all approximately 10 mm in diameter, and the rate of postoperative bleeding did not differ according to ulcer size.</p><p>Two of the three pigs with delayed hemorrhage had decreased hemoglobin levels and tarry stools in the ileum and cecum after 1 day. In contrast, all the pigs without delayed hemorrhage had increased hemoglobin levels and no tarry stools after 1 day.</p></sec><sec id="deo2411-sec-0140"><title>DISCUSSION</title><p>In the present study, we established an animal model of delayed bleeding by administering heparin to miniature swine following an endoscopic procedure of the gastric mucosa. To the best of our knowledge, this is the first animal model for delayed bleeding after endoscopic procedures. The establishment of an animal model of delayed bleeding after an endoscopic procedure is crucial for validating methods and new techniques for preventing delayed bleeding.</p><p>The swine is the most accepted surgical model because its physiological and anatomical characteristics are similar to those of humans.<xref rid="deo2411-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="deo2411-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="deo2411-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> The primary biological function of heparin is to inhibit FIIa and FXa in the coagulation cascade, and it has been used in various settings. Heparin can be administered intravenously (bolus or continuous) or subcutaneously.<xref rid="deo2411-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="deo2411-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> A recent study reported that heparin can be safely administered in animals while monitoring ACT until the ACT is &#x0003e;200 s.<xref rid="deo2411-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> ACT can represent overall blood coagulation capacity as influenced by activated partial thromboplastin time, prothrombin time, and platelets.<xref rid="deo2411-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> Therefore, we used the ACT to monitor the effects of heparin in swine. In humans, the goal should be &#x02265;400&#x02013;480 s during artificial heart&#x02010;lung management, &#x02265;250 s during percutaneous coronary intervention, and 180&#x02013;200 s for percutaneous cardiopulmonary support and intra&#x02010;aortic balloon pumping.<xref rid="deo2411-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>, <xref rid="deo2411-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>, <xref rid="deo2411-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> Thus, 220 s is not too high and is considered reasonable from an animal safety perspective.</p><p>We used a cut&#x02010;down method that allowed the placement of a catheter in the external jugular vein and reliable administration of heparin. A portable continuous infusion pump was used to administer a defined amount of heparin for an extended period. To the best of our knowledge, no previous studies have investigated the continuous administration of heparin in swine using this method.</p><p>In this study, we chose an EMR&#x02010;L method for gastric mucosal resection. EMR&#x02010;L allows the resection of more submucosal layers than EMR,<xref rid="deo2411-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> resulting in a mucosal defect similar to that in ESD. Furthermore, EMR&#x02010;L allows uniform mucosal defects to be performed in a shorter time. The reason for creating 12 mucosal defects in the stomach was that it was unclear which areas of the swine stomach were more prone to bleeding.</p><p>Our study has several limitations. First, this was a preclinical animal study involving only seven swine. Second, in clinical practice, various antithrombotic agents are used, including antiplatelet agents such as aspirin and anticoagulants such as warfarin and directly acting oral anticoagulants. However, only heparin was used in this study. In the future, postendoscopic treatment models using various antithrombotic agents should be established. Third, we confirmed the effects of heparin on ACT, although the anticoagulant effect of heparin is usually monitored using activated partial thromboplastin time.<xref rid="deo2411-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> This is because ACT can represent the overall coagulability<xref rid="deo2411-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> and can be measured more quickly than activated partial thromboplastin time. Fourth, EMR&#x02010;L was used in this study to induce mucosal injury. As outlined above, EMR&#x02010;L can create a uniform submucosal resection, but the method is strictly different from ESD, in which delayed bleeding is a problem, and a post&#x02010;ESD bleeding model also needs to be investigated.</p><p>In conclusion, an animal model of delayed bleeding after an endoscopic procedure in the gastrointestinal tract was established using a single dose of heparin and continuous heparin administration after confirming an ACT of 220 s. This model can potentially be used for various endoscopic procedures, simulations, and developments of new medical devices.</p></sec><sec sec-type="COI-statement" id="deo2411-sec-0160"><title>CONFLICT OF INTEREST STATEMENT</title><p>None.</p></sec><sec id="deo2411-sec-0170"><title>ETHICS STATEMENT</title><p>Informed Consent: N/A</p><p>Registry and the Registration No. of the study/trial: N/A</p><p>Animal Studies: All experiments were approved by the Animal Care and Use Committee of Kagoshima University (Approval number: MD22039). These animal experiments conform to the institutional standards of the Committee for Animal Research of Kagoshima University.</p></sec></body><back><ack id="deo2411-sec-0150"><title>ACKNOWLEDGMENTS</title><p>We would like to thank Editage (<ext-link xlink:href="http://www.editage.jp" ext-link-type="uri">www.editage.jp</ext-link>) for English language editing.</p></ack><ref-list id="deo2411-bibl-0001"><title>REFERENCES</title><ref id="deo2411-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="deo2411-cit-0001">
<string-name>
<surname>Pimentel&#x02010;Nunes</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Dinis&#x02010;Ribeiro</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ponchon</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) guideline</article-title>. <source>Endoscopy</source>
<year>2015</year>; <volume>47</volume>: <fpage>829</fpage>&#x02013;<lpage>854</lpage>.<pub-id pub-id-type="pmid">26317585</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="deo2411-cit-0002">
<string-name>
<surname>Oda</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Gotoda</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hamanaka</surname>
<given-names>H</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Endoscopic submucosal dissection for early gastric cancer: Technical feasibility, operation time and complications from a large consecutive series</article-title>. <source>Dig Endosc</source>
<year>2005</year>; <volume>17</volume>: <fpage>54</fpage>&#x02013;<lpage>58</lpage>.</mixed-citation></ref><ref id="deo2411-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="deo2411-cit-0003">
<string-name>
<surname>Chung</surname>
<given-names>IK</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>SH</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study</article-title>. <source>Gastrointest Endosc</source>
<year>2009</year>; <volume>69</volume>: <fpage>1228</fpage>&#x02013;<lpage>1235</lpage>.<pub-id pub-id-type="pmid">19249769</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="deo2411-cit-0004">
<string-name>
<surname>Isomoto</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Shikuwa</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yamaguchi</surname>
<given-names>N</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Endoscopic submucosal dissection for early gastric cancer: A large&#x02010;scale feasibility study</article-title>. <source>Gut</source>
<year>2009</year>; <volume>58</volume>: <fpage>331</fpage>&#x02013;<lpage>336</lpage>.<pub-id pub-id-type="pmid">19001058</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="deo2411-cit-0005">
<string-name>
<surname>Park</surname>
<given-names>YM</given-names>
</string-name>, <string-name>
<surname>Cho</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>HY</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>JM</given-names>
</string-name>. <article-title>The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: A systematic review and metaanalysis</article-title>. <source>Surg Endosc</source>
<year>2011</year>; <volume>25</volume>: <fpage>2666</fpage>&#x02013;<lpage>2677</lpage>.<pub-id pub-id-type="pmid">21424201</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="deo2411-cit-0006">
<string-name>
<surname>Yano</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tanabe</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ishido</surname>
<given-names>K</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Different clinical characteristics associated with acute bleeding and delayed bleeding after endoscopic submucosal dissection in patients with early gastric cancer</article-title>. <source>Surg Endosc</source>
<year>2017</year>; <volume>31</volume>: <fpage>4542</fpage>&#x02013;<lpage>4550</lpage>.<pub-id pub-id-type="pmid">28378078</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="deo2411-cit-0007">
<string-name>
<surname>Hatta</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Tsuji</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yoshio</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Prediction model of bleeding after endoscopic submucosal dissection for early gastric cancer: BEST&#x02010;J score</article-title>. <source>Gut</source>
<year>2021</year>; <volume>70</volume>: <fpage>476</fpage>&#x02013;<lpage>484</lpage>.<pub-id pub-id-type="pmid">32499390</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="deo2411-cit-0008">
<string-name>
<surname>Kubota</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ooba</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kamijima</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Koide</surname>
<given-names>D</given-names>
</string-name>. <article-title>The use of anticoagulants in patients with non&#x02010;valvular atrial fibrillation between 2005 and 2014: A drug utilization study using claims data in Japan</article-title>. <source>PLoS One</source>
<year>2018</year>; <volume>13</volume>: <elocation-id>e0203380</elocation-id>.<pub-id pub-id-type="pmid">30183755</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="deo2411-cit-0009">
<string-name>
<surname>Ohman</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Bhatt</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Steg</surname>
<given-names>PG</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>The REduction of Atherothrombosis for Continued Health (REACH) Registry: An international, prospective, observational investigation in subjects at risk for atherothrombotic events&#x02010;study design</article-title>. <source>Am Heart J</source>
<year>2006</year>; <volume>151</volume>: <fpage>786</fpage>.e1&#x02013;e10.</mixed-citation></ref><ref id="deo2411-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="deo2411-cit-0010">
<string-name>
<surname>Saito</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Tsuji</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sakaguchi</surname>
<given-names>Y</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Complications related to gastric endoscopic submucosal dissection and their managements</article-title>. <source>Clin Endosc</source>
<year>2014</year>; <volume>47</volume>: <fpage>398</fpage>&#x02013;<lpage>403</lpage>.<pub-id pub-id-type="pmid">25324997</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="deo2411-cit-0011">
<string-name>
<surname>Takizawa</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Oda</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Gotoda</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Routine coagulation of visible vessels may prevent delayed bleeding after endoscopic submucosal dissection &#x02212; An analysis of risk factors</article-title>. <source>Endoscopy</source>
<year>2008</year>; <volume>40</volume>: <fpage>179</fpage>&#x02013;<lpage>183</lpage>.<pub-id pub-id-type="pmid">18322872</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="deo2411-cit-0012">
<string-name>
<surname>Miyahara</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Iwakiri</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Shimoda</surname>
<given-names>R</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Perforation and postoperative bleeding of endoscopic submucosal dissection in gastric tumors: Analysis of 1190 lesions in low&#x02010; and high&#x02010;volume centers in Saga, Japan</article-title>. <source>Digestion</source>
<year>2012</year>; <volume>86</volume>: <fpage>273</fpage>&#x02013;<lpage>280</lpage>.<pub-id pub-id-type="pmid">22986899</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="deo2411-cit-0013">
<string-name>
<surname>Kataoka</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tsuji</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sakaguchi</surname>
<given-names>Y</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Bleeding after endoscopic submucosal dissection: Risk factors and preventive methods</article-title>. <source>World J Gastroenterol</source>
<year>2016</year>; <volume>22</volume>: <fpage>5927</fpage>&#x02013;<lpage>5935</lpage>.<pub-id pub-id-type="pmid">27468187</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="deo2411-cit-0014">
<string-name>
<surname>Chen</surname>
<given-names>VK</given-names>
</string-name>, <string-name>
<surname>Marks</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>RC</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Creation of an effective and reproducible nonsurvival porcine model that simulates actively bleeding peptic ulcers</article-title>. <source>Gastrointest Endosc</source>
<year>2008</year>; <volume>68</volume>: <fpage>548</fpage>&#x02013;<lpage>553</lpage>.<pub-id pub-id-type="pmid">18620348</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="deo2411-cit-0015">
<string-name>
<surname>Chiu</surname>
<given-names>PW</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Lau</surname>
<given-names>JY</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>LC</given-names>
</string-name>, <string-name>
<surname>Sung</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Chung</surname>
<given-names>SS</given-names>
</string-name>. <article-title>Endoscopic plication of massively bleeding peptic ulcer by using the Eagle Claw VII device: A feasibility study in a porcine model</article-title>. <source>Gastrointest Endosc</source>
<year>2006</year>; <volume>63</volume>: <fpage>681</fpage>&#x02013;<lpage>685</lpage>.<pub-id pub-id-type="pmid">16564872</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="deo2411-cit-0016">
<string-name>
<surname>Hu</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Chung</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>LC</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Developing an animal model of massive ulcer bleeding for assessing endoscopic hemostatic devices</article-title>. <source>Endoscopy</source>
<year>2005</year>; <volume>37</volume>: <fpage>847</fpage>&#x02013;<lpage>851</lpage>.<pub-id pub-id-type="pmid">16116536</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="deo2411-cit-0017">
<string-name>
<surname>Camus</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Marteau</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Pocard</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Validation of a live animal model for training in endoscopic hemostasis of upper gastrointestinal bleeding ulcers</article-title>. <source>Endoscopy</source>
<year>2013</year>; <volume>45</volume>: <fpage>451</fpage>&#x02013;<lpage>457</lpage>.<pub-id pub-id-type="pmid">23733728</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="deo2411-cit-0018">
<string-name>
<surname>Kubo</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yamashita</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Saito</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Heparinized swine models for better surgical/endoscopic training</article-title>. <source>DEN Open</source>
<year>2022</year>; <volume>2</volume>: <elocation-id>e64</elocation-id>.<pub-id pub-id-type="pmid">35310757</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="deo2411-cit-0019">
<string-name>
<surname>Kabayama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sasaki</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Hidehito</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Effects of sprayable, highly adhesive hydrophobized gelatin microparticles on endoscopic submucosal dissection: A swine model</article-title>. <source>Digestion</source>
<year>2023</year>; <volume>104</volume>: <fpage>137</fpage>&#x02013;<lpage>147</lpage>.<pub-id pub-id-type="pmid">36470222</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="deo2411-cit-0020">
<string-name>
<surname>Suzuki</surname>
<given-names>H</given-names>
</string-name>. <article-title>Endoscopic mucosal resection using ligating device for early gastric cancer</article-title>. <source>Gastrointest Endosc Clin N Am</source>
<year>2001</year>; <volume>11</volume>: <fpage>511</fpage>&#x02013;<lpage>518</lpage>.<pub-id pub-id-type="pmid">11778752</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0021"><label>21</label><mixed-citation publication-type="book" id="deo2411-cit-0021">
<string-name>
<surname>Yahagi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kato</surname>
<given-names>M</given-names>
</string-name>. <part-title>Endoscopic treatment: EMR and ESD</part-title>. In: <person-group person-group-type="editor">
<string-name>
<surname>Ando</surname>
<given-names>N</given-names>
</string-name>
</person-group> (ed). <source>Esophageal Squamous Cell Carcinoma</source>, <edition>1st edn</edition>, <publisher-loc>Singapore</publisher-loc>: <publisher-name>Springer</publisher-name>, <year>2022</year>; <fpage>149</fpage>&#x02013;<lpage>160</lpage>.</mixed-citation></ref><ref id="deo2411-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="deo2411-cit-0022">
<string-name>
<surname>Murokawa</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sahara</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sekijima</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>The protective effects of carbon monoxide against hepatic warm ischemia&#x02010;reperfusion injury in MHC&#x02010;inbred miniature swine</article-title>. <source>J Gastrointest Surg</source>
<year>2020</year>; <volume>24</volume>: <fpage>974</fpage>&#x02013;<lpage>982</lpage>.<pub-id pub-id-type="pmid">31243716</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="deo2411-cit-0023">
<string-name>
<surname>Hirsh</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Anand</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Halperin</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Fuster</surname>
<given-names>V</given-names>
</string-name>. <article-title>Mechanism of action and pharmacology of unfractionated heparin</article-title>. <source>Arterioscler Thromb Vasc Biol</source>
<year>2001</year>; <volume>21</volume>: <fpage>1094</fpage>&#x02013;<lpage>1096</lpage>.<pub-id pub-id-type="pmid">11451734</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="deo2411-cit-0024">
<string-name>
<surname>Matsumoto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mabe</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tsuda</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Multicenter study on hemorrhagic risk of heparin bridging therapy for periendoscopic thromboprophylaxis</article-title>. <source>BMC Gastroenterol</source>
<year>2015</year>; <volume>15</volume>: <fpage>89</fpage>.<pub-id pub-id-type="pmid">26215103</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="deo2411-cit-0025">
<string-name>
<surname>Horton</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Augustin</surname>
<given-names>S</given-names>
</string-name>. <article-title>Activated clotting time (ACT)</article-title>. <source>Methods Mol Biol</source>
<year>2013</year>; <volume>992</volume>: <fpage>155</fpage>&#x02013;<lpage>167</lpage>.<pub-id pub-id-type="pmid">23546712</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="deo2411-cit-0026">
<string-name>
<surname>Shore&#x02010;Lesserson</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Baker</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Ferraris</surname>
<given-names>V</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>STS/SCA/AmSECT clinical practice guidelines: Anticoagulation during cardiopulmonary bypass</article-title>. <source>J Extra Corpor Technol</source>
<year>2018</year>; <volume>50</volume>: <fpage>5</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="pmid">29559750</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="deo2411-cit-0027">
<string-name>
<surname>Nishimura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hirata</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ise</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>JCS/JSCVS/JCC/CVIT 2023 guideline focused update on indication and operation of PCPS/ECMO/IMPELLA</article-title>. <source>Circulation Journal</source>
<year>2024</year>; <volume>88</volume>: <fpage>1010</fpage>&#x02013;<lpage>1046</lpage>.<pub-id pub-id-type="pmid">38583962</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="deo2411-cit-0028">
<string-name>
<surname>O'Gara</surname>
<given-names>PT</given-names>
</string-name>, <string-name>
<surname>Kushner</surname>
<given-names>FG</given-names>
</string-name>, <string-name>
<surname>Ascheim</surname>
<given-names>DD</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>2013 ACCF/AHA guideline for the management of ST&#x02010;elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines</article-title>. <source>J Am Coll Cardiol</source>
<year>2013</year>; <volume>61</volume>: <fpage>e78</fpage>&#x02013;<lpage>e140</lpage>.<pub-id pub-id-type="pmid">23256914</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="deo2411-cit-0029">
<string-name>
<surname>Hong</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Baek</surname>
<given-names>DH</given-names>
</string-name>. <article-title>Endoscopic treatment for rectal neuroendocrine tumor: Which method is better?</article-title>
<source>Clin Endosc</source>
<year>2022</year>; <volume>55</volume>: <fpage>496</fpage>&#x02013;<lpage>506</lpage>.<pub-id pub-id-type="pmid">35811403</pub-id>
</mixed-citation></ref><ref id="deo2411-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="deo2411-cit-0030">
<string-name>
<surname>Hirsh</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Warkentin</surname>
<given-names>TE</given-names>
</string-name>, <string-name>
<surname>Raschke</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Granger</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ohman</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Dalen</surname>
<given-names>JE</given-names>
</string-name>. <article-title>Heparin and low&#x02010;molecular&#x02010;weight heparin: Mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety</article-title>. <source>Chest</source>
<year>1998</year>; <volume>114</volume>: <fpage>489S</fpage>&#x02013;<lpage>510S</lpage>.<pub-id pub-id-type="pmid">9822059</pub-id>
</mixed-citation></ref></ref-list></back></article>